Balyasny Asset Management LLC Voyager Therapeutics, Inc. Transaction History

Balyasny Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$7.15 - $10.84 $152,588 - $231,336	21,341 New	21,341 $198,000
Q3 2019 Nov 14, 2019	SELL	$16.31 - $28.29 $570,262 - $989,131	-34,964 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$19.18 - $27.88 $670,609 - $974,796	34,964 New	34,964 $952,000
Q4 2018 Feb 14, 2019	SELL	$8.59 - $18.05 $169,600 - $356,379	-19,744 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$17.11 - $21.74 $2,994 - $3,804	175 Added 0.89%	19,744 $374,000
Q2 2018 Aug 14, 2018	BUY	$16.76 - $23.92 $132,303 - $188,824	7,894 Added 67.61%	19,569 $382,000
Q1 2018 May 15, 2018	SELL	$16.16 - $31.31 $2.46 Million - $4.76 Million	-152,136 Reduced 92.87%	11,675 $219,000
Q4 2017 Feb 14, 2018	BUY	$12.26 - $25.88 $2.01 Million - $4.24 Million	163,811	163,811 $2.72 Million

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.